HOME >> MEDICINE >> NEWS
Report 13 in RERF study of mortality of A-bomb survivors extends coverage through 1997

Report 13 in an ongoing series of reports from the Radiation Effects Research Foundation (RERF) on mortality in the Life Span Study (LSS) cohort of A-bomb survivors addresses solid cancer and noncancer disease mortality for the years 1950-1997.

Authored by Dale Preston and his colleagues Yukiko Shimizu, Donald A. Pierce, Akihiko Suyama and Kiyohiko Mabuchi, the study appears in the October issue of Radiation Research.

The authors found that while excess rates for radiation-related cancers have increased throughout the study period, relative risks have declined with increasing attained age. As noted in previous reports, the relative risks are highest for those exposed as children.

No significant difference between cities (Hiroshima and Nagasaki) has been found for either the relative or absolute excess solid cancer risk.

Evidence for radiation effects on noncancer mortality continues to be strong, with statistically significant increases for heart disease, digestive diseases, and respiratory diseases.

The cohort studied consists of over 86,000 people with individual dose estimates, with 60% having doses of at least 5 mSv.


'"/>

Contact: Dale L. Preston
preston@rerf.or.jp
Radiation Research Society
20-Oct-2003


Page: 1

Related medicine news :

1. National Academies advisory: Report assesses health implications of perchlorate exposure
2. Report on health insurance coverage of Iowa children shows gaps
3. Report finds new model of care can improve quality, lower costs and increase physician efficiency
4. Michelle Trudeau wins 2004 Victor Cohn Prize for Excellence in Medical Reporting
5. Oct. 14 Web cast: Reporters Workshop -- Covering Vaccines & Immunizations
6. Latest Public Policy & Aging Report forecasts possible US labor shortage
7. Report finds inactivated influenza virus vaccines effective in children
8. Microneedles: Report describes progress in new technology for painless drug delivery
9. Report gives NIH-sponsored clinical research a good report card
10. Report cites risks associated with over-the-counter cosmetic contact lenses
11. Report shows high arsenic in some southeast NH private wells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... February 24, 2017 , ... With ProGlass Prism users now have ... Users have total control over position, rotation, distortion, edge softness, edge blur, chromatic aberration, ... Pro X. , With ProGlass Prism users are given the tools and effects ...
(Date:2/24/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... Yisrayl makes an astounding statement when he says that the entire Bible was ... details the current times so plainly that anyone should be able to see the ...
(Date:2/24/2017)... ... 24, 2017 , ... Indiana Fiber Network (IFN) President and CEO Kelly C. ... Dyer started as the Chairman of the Management Committee when IFN was originally formed ... the recruitment of investor/owners and development of the business plan. He became the ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... marketing services, which specializes in thought leadership , media relations, social media, ... and services that will be powered through Act-On, an intuitive marketing automation platform. ...
(Date:2/24/2017)... MI (PRWEB) , ... February 24, 2017 , ... ... in Charlevoix, once again hosted their Military Wedding Giveaway, with the winning ... hosted by Castle Farms with services generously donated from local vendors: A Matter ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX: ITD ), ... für das zum 31. Dezember 2016 endende Halbjahr ... vorlegen zu können. Eine vollständige Präsentation „Ergebnisse von ... Sie hier . Glanzpunkte ... 2015: 1,04 Millionen USD; +104 %) Gewinn je ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
Breaking Medicine Technology:
Cached News: